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Venous thromboembolism is a significant cause of
morbidity and mortality in the United States, with
approximately 500,000 new cases of deep venous
thrombosis (DVT) and an estimated 50,000 to
150,000 deaths from pulmonary embolism (PE) each
year.1 PE is the third leading cause of death from car-
diovascular disease, exceeded only by ischemic heart
disease and stroke, and may be the most common
preventable cause of death in hospitals.2
Patients who require major surgical procedures
are considered to be at a higher risk for venous
thromboembolic complications. Previously identi-
fied high-risk groups include patients with major
traumatic injuries and those undergoing orthope-
dic, neurosurgical, and intra-abdominal general sur-
gical procedures. In these high-risk groups, the
effectiveness of DVT prophylaxis has been clearly
demonstrated, and its routine use in these patients
is recommended.3-5
The risk of venous thromboembolic complica-
tions in patients undergoing peripheral vascular
surgery is not well documented. Because patients
undergoing vascular reconstruction receive intraop-
erative systemic heparin during the period of vascular
clamping, the risk of DVT is assumed to be low.
However, predisposing factors may possibly increase
the risk of DVT in this population, including preop-
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erative limb ischemia, increased postoperative limb
edema and pain, prolonged immobility, and associat-
ed hypercoagulable states.6-8 Because the incidence
of DVT in patients undergoing lower extremity
revascularization is not well documented, recom-
mendations for routine prophylaxis cannot be 
established. The purpose of this study was to
prospectively evaluate the risk of DVT in patients
undergoing infrainguinal revascularization.
METHODS
Patient enrollment. A prospective cohort study
was designed to evaluate the risk of DVT in patients
undergoing infrainguinal bypass grafting for lower
extremity arterial ischemia. The Institutional Review
Board approved the study, and informed consent
was obtained before enrollment. Between January 1
and December 31, 1998, patients undergoing
infrainguinal bypass grafting at the University of
North Carolina Medical Center in Chapel Hill were
approached concerning enrollment in the study and
were assessed for eligibility. Those included were
patients with chronic lower extremity arterial
ischemia resulting from atherosclerotic occlusive dis-
ease who were electively scheduled for infrainguinal
bypass grafting. Exclusion criteria included (1) acute
lower extremity arterial ischemia requiring urgent
intervention, (2) lower extremity arterial ischemia
resulting from nonatherosclerotic disease, (3) the
need for simultaneous multilevel reconstruction,
and (4) an unwillingness to participate in the study.
Study protocol. Enrolled patients gave a preop-
erative comprehensive medical history and under-
went a physical examination. In addition to routine
laboratory and radiographic studies required for the
operation, preoperative bilateral lower extremity
venous duplex scan imaging was obtained to docu-
ment the absence of DVT. Patients with DVT found
before surgery were excluded from the study proto-
col. Serum laboratory tests to evaluate for a potential
hypercoagulable condition were obtained just before
operation. Serum tests included anticardiolipin anti-
bodies (immunoglobulin G 0-23, immunoglobulin
M 0-11), lupus inhibitor (lupus inhibitor screen,
hexagonal phospholipid assay, and dilute Russell’s
viper venom time), antithrombin III (level 70%-
118%), factor V Leiden (DNA polymerase chain
reaction assay), homocysteine (total plasma serum
level 5-16 µmol/L), protein C (activity 65%-178%),
and protein S (activity 65%-178%, total level 78%-
163%, free level 60%-161%). 
Patients underwent infrainguinal bypass grafting
for lower extremity arterial ischemia with the con-
duit and target vessels determined by the surgical
team. During bypass graft operation, patients
received standard heparin doses of 5000 units intra-
venously before vascular clamping, with additional
doses of 1000 units received intravenously at
approximately 1-hour intervals until completion of
the final graft anastomosis. 
Routine postoperative DVT prophylaxis with anti-
coagulation or sequential compression devices was not
used. Postoperative anticoagulation with intravenous
unfractionated heparin followed by warfarin sodium
(Coumadin) was reserved for patients with preexisting
hypercoagulable states, prior thromboembolic events,
and previous bypass graft failures; for patients who
required anticoagulation preoperatively for other indi-
cations; and for selected distal bypass graft procedures
at the discretion of the operating surgeon. All other
patients were treated with antiplatelet therapy, rou-
tinely aspirin, unless contraindicated. 
During the postoperative period, repeat bilateral
lower extremity venous duplex scan imaging was per-
formed within 1 week and 6 weeks, postoperatively.
If initial postoperative venous duplex scan imaging
was inconclusive, an additional scan was performed 2
weeks after the operation. Patients in whom DVT
was diagnosed during the postoperative period were
subsequently treated with anticoagulation. Patients
with abnormal hypercoagulable screening results
reported during the postoperative period who had
not been initially anticoagulated were subsequently
anticoagulated after obtaining bilateral lower extrem-
ity venous duplex scan imaging, but they were
included with patients who did not receive anticoag-
ulation on the basis of intent-to-treat. 
Venous imaging. Venous duplex scan imaging
was performed by registered vascular technologists
who used an Acuson XP-128 color flow duplex ultra-
sound scan (Acuson Inc, Mountain View, Calif).
Femoral, popliteal, and calf veins (anterior tibial, pos-
terior tibial, peroneal, and soleal veins) were routine-
ly evaluated.9,10 DVT was diagnosed with the criteria
of incompressibility, abnormal or absent color flow
images, and failure to increase flow with distal aug-
mentation within an insonated vein segment.11
Statistical analysis. Sample size calculations were
performed before enrollment on the basis of an esti-
mate for a descriptive study of dichotomous variables
(N = 4zα2P(1-P)/W2, where N = estimated sample
size, P = expected proportion, W = total width of CI,
and zα = standard normal deviate for a 2-tailed α
where [1-α] is the confidence level). Assuming an
expected proportion (P) of 0.05 with a total width of
CI (W) of 0.10, a 90% confidence level would require
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an estimated sample size (N) of 51 patients, and a 95%
confidence level would require 73 patients.12-15
The presence of postoperative DVT in patients
undergoing infrainguinal bypass grafting for lower
extremity arterial ischemia was the primary prospective
end point of this study. Secondary comparisons were
made with the use of χ2 analysis with statistical signifi-
cance defined as a P value of .05 or less for preopera-
tive risk factors, medical problems, surgical indications,
operative technique, use of postoperative anticoagula-
tion, and abnormal hypercoagulable screening. 
RESULTS
Seventy-four patients undergoing infrainguinal
bypass grafting for lower extremity arterial ischemia
during the 12-month period met the inclusion
requirements and were screened for enrollment into
the study. Of these 74 patients, three (4.1%) had
DVT revealed through preoperative venous duplex
scan imaging and were excluded from the study. The
remaining 71 patients were prospectively enrolled
into the study protocol. The mean age of the
patients was 69.1 ± 10.2 years (range, 36-87 years);
50.7% of the patients were men and 49.3% women.
The associated medical problems and risk factors are
shown in Table I, and the surgical indications and
infrainguinal bypass graft operations performed are
shown in Table II. 
Bilateral lower extremity venous duplex scan
imaging was obtained as per study protocol on all 71
patients within 1 week after the operation (mean,
4.9 ± 3.1 days). An additional venous duplex ultra-
sound scan was required at the 2-week interval in
eight patients (11.3%) because of limited calf vein
imaging in seven patients and femoral vein imaging
in one patient due to leg edema, pain, or both dur-
ing the initial venous duplex scan. Therefore, within
2 weeks of surgery, all patients in the study under-
went a complete venous duplex ultrasound scan
examination. Late follow-up venous duplex scan
imaging 6 weeks after the operation (mean, 44.1 ±
6.2 days) was obtained in 60 (85.9%) of the 71
patients, with 11 patients (14.1%) lost to follow-up.
Of the 71 patients enrolled in the study, only two
patients (2.8%) had postoperative DVT. Both were
identified through venous duplex scan imaging
within the 1-week interval. Postoperative DVT was
ipsilateral to the bypass graft extremity in both
patients, with involvement of the peroneal vein in
one patient and the femoral vein in the other.
Although routine DVT prophylaxis was not used in
this study, 18 patients (25.4%) were anticoagulated
during the postoperative period because of preexist-
ing hypercoagulable states (1), prior thromboem-
bolic events (2), previous bypass graft failures (8),
preoperative anticoagulation for other indications
(4), and selected distal bypass graft procedures at the
discretion of the operating surgeon (3). Of these 18
patients, only one (5.6%) had postoperative DVT.
Of the remaining 53 patients who did not receive
postoperative anticoagulation, only one patient
(1.8%) had DVT. There was no difference in post-
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Table I. Preoperative medical problems and venous thromboembolic risk factors in 71 patients screened for
postoperative DVT after infrainguinal revascularization for chronic lower extremity arterial ischemia
Medical problems No. of patients (%) Risk factors No. of patients (%)
Tobacco abuse 61 (85.9) Prior DVT/PE 2 (2.8)
Hypertension 53 (74.6) Hypercoagulable state 1 (1.4) 
Diabetes mellitus 48 (67.6) 
Cardiac disease 39 (54.9) Prior limb surgery* 10 (14.1) 
Hyperlipidemia 17 (23.9) Prior limb trauma 6 (8.5)
Stroke 12 (16.9) Immobility 6 (8.5) 
Renal failure 10 (14.1) Malignancy 5 (7.0)
Pulmonary disease 4 (5.6) Morbid obesity 3 (4.2)
Prior abdominal surgery 33 (46.5)
Prior CABG 11 (15.5)
Prior vascular surgery† 30 (42.3)
Leg bypass graft 19 (26.8)
Major amputation 10 (14.1)
Aortic bypass graft 3 (4.2)
Extra-anatomic bypass graft 2 (2.8)
Carotid endarterectomy 2 (2.8)
*Prior limb surgery other than vascular operations. 
†Number of prior vascular operations are listed for patients in the study (N = 71).
CABG, Coronary artery bypass grafting.
operative DVT between patients treated with and
without anticoagulation. There was also no differ-
ence between patients with and without postopera-
tive DVT in terms of preoperative risk factors, med-
ical problems, surgical indications, and operative
technique, although this lack of correlation may rep-
resent a potential Type II statistical error. Although
not part of the study protocol, patients with DVT
found preoperatively received postoperative antico-
agulation, with no evidence of thrombus propaga-
tion on subsequent venous duplex scan imaging. No
patients in this study experienced clinical symptoms
compatible with PE.
Of the 71 patients in the study, 22 (31.0%) had
abnormal results from a hypercoagulable serum-
screening laboratory test, including one patient with
a preexisting hypercoagulable state (protein C defi-
ciency) (Table III). There was no statistical difference
in postoperative DVT in patients with abnormal find-
ings from hypercoagulable screening (4.5%) com-
pared with patients with normal serum test results
(2.0%). Nine (40.9%) of the 22 patients with abnor-
mal findings from hypercoagulable screening had
received postoperative anticoagulation before report-
ing of the abnormal results. The remaining 13
patients who had not been initially anticoagulated
after the operation were subsequently anticoagulated
after obtaining venous duplex scan imaging, but were
included with patients who did not receive anticoag-
ulation based on intent-to-treat. Of the two patients
with postoperative DVT, one patient had a preexist-
ing hypercoagulable state and was already anticoagu-
lated. The other patient with postoperative DVT had
not been anticoagulated and had normal results from
the hypercoagulable screening serum laboratory test.
DISCUSSION
Patients who require major surgical procedures
and are considered to be at increased risk for venous
thromboembolic complications include those under-
going orthopedic, neurosurgical, and intra-abdominal
general surgical procedures, and patients with major
traumatic injuries.3-5 The risk of venous thromboem-
bolic complications in patients undergoing peripheral
vascular surgery is not well documented.
Most of the previous studies on the risk of post-
operative DVT in patients undergoing peripheral
vascular surgery are after aortic reconstruction, with
a reported incidence of DVT ranging from 1.5% to
26%.12,13-23 This inconsistency may reflect variabili-
ty in the diagnostic methods used for detecting
DVT. Furthermore, although some of these series
report a high incidence of DVT, this mostly repre-
sents a higher proportion of calf vein thrombosis.
Olin et al20 reported an incidence of 18% in 50
patients undergoing abdominal aortic aneurysm
repair as documented through venography, with
78% of the thrombi confined to the calf veins. In
contrast, Killewich et al20 reported a 2% incidence of
postoperative DVT identified with venous duplex
ultrasound scan in a randomized prospective trial of
100 patients undergoing aortic reconstruction with
and without DVT prophylaxis, although the venous
duplex ultrasound scan protocol used in this study
did not include insonation of calf veins. Because of
the variability in these studies, the true incidence of
DVT in patients undergoing aortic reconstruction
remains uncertain, and recommendations for rou-
tine prophylaxis have not been established. 
Although most studies in which the risk of
venous thromboembolic complications in patients
undergoing peripheral vascular surgery is evaluated
have focused on aortic reconstruction, there have
only been a few reports examining the risk of DVT in
patients undergoing infrainguinal bypass grafting.
Researchers investigating the cause of leg edema after
lower extremity revascularization have suggested a
variable incidence of DVT. Although Hamer et al21
reported that 42% of 21 patients had DVT revealed
through venography after femoropopliteal bypass
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Table II. Surgical indications and bypass graft operations in 71 patients screened for postoperative DVT after
infrainguinal revascularization for chronic lower extremity arterial ischemia
Surgical indications No. of patients (%) Operation No. of patients (%)
Ischemic ulceration 46 (64.8) Above-knee popliteal 6 (8.5) 
Rest pain 19 (26.7) Below-knee popliteal 15 (21.1) 
Claudication 6 (8.5) Tibial 37 (52.1)
Pedal 13 (18.3)
In situ vein graft 32 (45.1)
Reversed vein graft 23 (32.4)
Composite vein graft 9 (12.7)
Synthetic graft 7 (9.8)
grafting, DVT more commonly was isolated to the
tibial veins, and the incidence seemed to be higher in
patients with increased lower extremity edema.
Myhre et al13 reported that in 25 patients with
edema after lower extremity arterial reconstruction,
only 8% had DVT revealed through venography.
Similarly, AbuRahma et al14 reported that six (8.3%)
of 72 patients undergoing lower extremity bypass
graft surgery had documented postoperative DVT
and that venous thrombosis was not an important
cause of leg edema. 
Other studies in which the general risk of DVT
after peripheral vascular operations is evaluated have
included lower extremity infrainguinal bypass grafting
as part of a larger study of other vascular procedures.
Fletcher and Batiste12 reported a total incidence of
9.8% in 146 consecutive patients after peripheral vas-
cular surgery, which included a 9.2% incidence in 54
patients undergoing infrainguinal revascularization.
In a randomized controlled trial in which low molec-
ular weight heparin was compared with unfractionat-
ed heparin for DVT prophylaxis, 87 of 233 patients
had undergone lower extremity bypass grafting with a
3.4% postoperative DVT rate.15
In this study, we prospectively evaluate the risk of
DVT in patients undergoing only infrainguinal
revascularization. Sample size determination was
made assuming a 5% incidence of DVT with a total
width of CI of 10%. Seventy-one patients with
chronic lower extremity arterial ischemia resulting
from atherosclerotic occlusive disease underwent
infrainguinal bypass grafting during a 12-month
period. Postoperative DVT was found in only 2.8%. 
There are several limitations with this study that
should be addressed. First, although venous duplex
ultrasound scan is accurate in screening symptomatic
patients for DVT, there is variable diagnostic accuracy
in screening asymptomatic postoperative patients.25
Because of this concern, in this study, if the venous
duplex scan imaging obtained within 1 week of oper-
ation was inadequate, a repeat scan was performed
within 2 weeks. With the use of standard venous
duplex ultrasound scan criteria, the initial scan was
technically adequate in imaging all lower extremity
venous segments in 88.7% of patients 1 week after
operation and in 100% at 2 weeks. Although historic
data with radiolabeled fibrinogen have suggested that
most early postoperative thrombi resolve rapidly,
especially for DVT limited to the calf,26 other studies
have shown that limbs with more proximal DVT may
have prolonged recanalization extending beyond 3
months.27,28 In this study, a late follow-up scan was
obtained at 6 weeks in 85.9% of the patients to con-
firm that a significant DVT, which may have been
missed during the earlier scans, was not present.
Because of these technical limitations and timing
issues, the incidence of DVT in this study may be
underestimated, although the clinical relevance of
potentially missed DVT is questionable. Second, the
presence of postoperative DVT in patients undergo-
ing infrainguinal bypass grafting for lower extremity
arterial ischemia was the primary prospective end
point of this study. Although secondary comparisons
were made with χ2 analysis for preoperative risk fac-
tors, medical problems, surgical indications, operative
technique, use of postoperative anticoagulation, and
abnormal results from hypercoagulable screening, the
lack of correlation may represent a potential Type II
statistical error because of the patient population size
relative to the low incidence of postoperative DVT.
Finally, as a prospective cohort study designed to eval-
uate the risk of DVT in patients undergoing infrain-
guinal bypass grafting for lower extremity arterial
ischemia, there was a mixture of patients included in
the study, some of whom were treated perioperatively
with antiplatelet therapy, whereas others were treated
with anticoagulation during the initial postoperative
period according to specific clinical criteria. An addi-
tional 13 patients required subsequent anticoagula-
tion after abnormal findings from hypercoagulable
screening, but for analysis were included with patients
not receiving anticoagulation on the basis of intent-
to-treat, with venous duplex scan imaging obtained
before initiation of anticoagulation. Although exclu-
sion of these patients would have created selection or
confounding bias and in an ideal study design no
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Table III. Abnormal hypercoagulable screening
serum laboratory test results in 22 (31%) of 71
patients evaluated for postoperative DVT after
infrainguinal revascularization for chronic lower
extremity arterial ischemia
Abnormal serum laboratory test N* (%)
Elevated plasma homocysteine 11 (15.5) 
Anticardiolipin antibodies 6 (8.5) 
Antithrombin III deficiency 3 (4.2) 
Protein C deficiency 2 (2.8)†
Protein S deficiency 2 (2.8)†
Lupus inhibitor 1 (1.4) 
Factor V Leiden mutation 1 (1.4)
*N = number of abnormal tests.
†Includes known preexisting protein C deficiency in one patient.
Although seven patients had been concurrently anticoagulated
with Coumadin during hypercoagulable screening, de novo pro-
tein C and S deficiency was found in three other patients who
were not anticoagulated.
patients would have been anticoagulated during the
postoperative period, this does not represent the clin-
ical spectrum of patients undergoing infrainguinal
revascularization. 
Although the risk of postoperative DVT after
infrainguinal revascularization is low, the potential for
DVT in patients with peripheral vascular disease may
be increased when compared with the general popu-
lation. Libertiny and Hands29 reported a 19.6% inci-
dence of DVT in 136 patients screened with venous
duplex ultrasound scan before arteriography, angio-
plasty, or arterial reconstruction, compared with 5% in
40 controls without peripheral arterial disease under-
going general surgical or urologic procedures. The
propensity of patients with peripheral vascular disease
for DVT may reflect preoperative limb ischemia, pro-
longed immobility, elevated plasma homocysteine lev-
els, and associated hypercoagulable states.6-8,30,31
Although our study was not intended to be a screen-
ing of patients with symptomatic peripheral vascular
disease, three (4.1%) of 74 patients screened before
undergoing lower extremity revascularization had
incidental lower extremity DVT. Although there may
be a higher prevalence of DVT in patients with
peripheral vascular disease compared to the general
population, according to our series, the risk does not
seem to be increased in patients before or after lower
extremity revascularization, with a 4.1% and 2.8%
incidence of DVT, respectively. Because patients are
not routinely screened for DVT in clinical practice,
the combined potential for undiagnosed DVT in
patients undergoing infrainguinal revascularization is
6.9%. Furthermore, despite 31% of patients in our
study with abnormal results from hypercoagulable
screening, the incidence of postoperative DVT
remained low, with no difference in postoperative
DVT in patients with and without abnormal hyperco-
agulable screening (4.5% and 2.0%, respectively).
Previously, because the incidence of DVT in
patients undergoing lower extremity revasculariza-
tion was unclear, recommendations for routine DVT
prophylaxis have not been established. According to
Fletcher and Batiste,12 the incidence of DVT after
lower extremity bypass grafting was 9.2% despite
5000 units of unfractionated heparin three times per
day. According to Farkas et al,15 there was no differ-
ence in postoperative DVT after infrainguinal revas-
cularization in patients receiving prophylaxis with
unfractionated heparin (2.5%) compared with
enoxaparin (4.3%). In our study, patients did not
receive routine DVT prophylaxis, although 25%
required anticoagulation for specific indication
including preexisting hypercoagulable states, prior
thromboembolic events, previous bypass graft fail-
ures, preoperative anticoagulation for other indica-
tions, and occasionally distal bypass graft procedures
at the discretion of the operating surgeon. There
was no difference in postoperative DVT in patients
who did and did not receive anticoagulation after
the operation (5.6% and 1.8%, respectively). On the
basis of this low risk of postoperative DVT, routine
prophylaxis is not recommended, with postoperative
anticoagulation reserved for specific indications.
Although this question can only be truly settled with
a prospective randomized trial, with such a low inci-
dence of DVT, a large patient cohort would be
required to detect minimal benefit with an increased
risk of bleeding complications and cost. 
CONCLUSION
According to this prospective cohort study, the
incidence of postoperative DVT in patients under-
going infrainguinal revascularization is low (2.8%).
Routine prophylaxis is not recommended, with post-
operative anticoagulation reserved for specific indi-
cations independent of the risk of DVT.
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